Files

Download

Download Full Text (259 KB)

Description

  • CentraCare hospitals were the first in Minnesota to identify a patient with Candida auris (C. auris), an emerging pathogen.
  • 2018 Centers for Disease Control and Prevention (CDC) and state health department recommended adoption of enhanced admission screening process to allow for early identification of patients at risk of being colonized with C. auris/Carbapenem-Resistant Organisms (CROs).
  • C. auris, a fungus, and CROs, comprised of organisms from the Enterobacteriaceae family resistant to carbapenems, are emerging multidrug resistant pathogens. Emphasis on identification and early isolation of at-risk patients decreases risk of transmission.

Publication Date

2022

Keywords

Candida auris, C. auris, EHR, Electronic Health Record, Travel screening, Isolation, Admission screening

Disciplines

Infectious Disease | Other Nursing

Comments

Nurses Week Poster 2022

Innovative Use of EHR to Support Admission Screening for Emerging Pathogens

Share

COinS